vialroom

#cagrilintide 2025-05-18

Sunday30 messages7 participantstimes are UTC
Highlights from this day
  • verify_or_dont — anyone stopped the GLP-1 and kept only this 20:57
  • eight_mm — noticed something around week 25 on monotherapy, well after i had given up expecting to 21:27
  • net_peptide — update on the earlier thing held at 2.4 for 4 months on monotherapy before i touched it again 22:05
  • deamidation — genuine question amylin is about slowed gastric emptying and satiety signalling, thats the short version and im no pharmacologist 22:07
  • net_peptide — dosing them on different days made no difference i could detect added it to an existing semaglutide dose rather than starting both, which made attribution possible 22:27
AA

the slower titration in here is community habit as much as anything, the trials had their own schedule

dropped the GLP-1 and stayed on this alone for 20 months, appetite held but weight barely moved

20:27tenpence pinned a message
NP

is there a reason people titrate this over more weeks than the others

AA

amylin not glp-1

weights-monthly.csv
442 rows · not retained in the public archive

fullness rather than nausea

GV

went slower because the first step gave me two rough days and i took that as information

[edited]
VO

did anyone add this to an existing cagrilintide dose rather than starting both

*Medutest not the other one

anyone stopped the GLP-1 and kept only this

💀4

*Medutest not the other one

GV

if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way

whats REDEFINE testing exactly

right so how do people separate which of the two is doing what in a combination

noticed something around week 25 on monotherapy, well after i had given up expecting to

📈162🙏7
DE

REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work

NP

update on the earlier thing held at 2.4 for 4 months on monotherapy before i touched it again

💀11👍2🤝8
DE

genuine question amylin is about slowed gastric emptying and satiety signalling, thats the short version and im no pharmacologist

💀18👀5
NP

i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something

dosing them on different days made no difference i could detect
added it to an existing semaglutide dose rather than starting both, which made attribution possible

AA

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

22:58tenpence pinned a message to this channel